Detalhe da pesquisa
1.
Real-World Experience in Treatment of Patients with Non-Small-Cell Lung Cancer with BRAF or cMET Exon 14 Skipping Mutations.
Int J Mol Sci
; 24(16)2023 Aug 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37629023
2.
Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden.
N Engl J Med
; 378(22): 2093-2104, 2018 May 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-29658845
3.
The patient's perspective on treatment with dacomitinib: patient-reported outcomes from the Phase III trial ARCHER 1050.
Future Oncol
; 17(7): 783-794, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33164569
4.
Four-year survival with nivolumab in patients with previously treated advanced non-small-cell lung cancer: a pooled analysis.
Lancet Oncol
; 20(10): 1395-1408, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31422028
5.
Effects of dose modifications on the safety and efficacy of dacomitinib for EGFR mutation-positive non-small-cell lung cancer.
Future Oncol
; 15(24): 2795-2805, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31313942
6.
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer.
N Engl J Med
; 373(2): 123-35, 2015 Jul 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-26028407
7.
Dacomitinib versus gefitinib as first-line treatment for patients with EGFR-mutation-positive non-small-cell lung cancer (ARCHER 1050): a randomised, open-label, phase 3 trial.
Lancet Oncol
; 18(11): 1454-1466, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28958502
8.
Dacomitinib versus erlotinib in patients with advanced-stage, previously treated non-small-cell lung cancer (ARCHER 1009): a randomised, double-blind, phase 3 trial.
Lancet Oncol
; 15(12): 1369-78, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25439691
9.
Clinicopathological characteristics of patients with primary tracheal tumors: Analysis of eighty-nine cases.
Thorac Cancer
; 15(11): 878-883, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38429910
10.
Nivolumab or Atezolizumab in the Second-Line Treatment of Advanced Non-Small Cell Lung Cancer? A Prognostic Index Based on Data from Daily Practice.
J Clin Med
; 12(6)2023 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36983409
11.
Treatment Patterns, Testing Practices, and Outcomes in Patients with EGFR Mutation-Positive Advanced Non-Small-Cell Lung Cancer in Poland: A Descriptive Analysis of National, Multicenter, Real-World Data from the REFLECT Study.
Cancers (Basel)
; 15(5)2023 Mar 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36900371
12.
Beta Blockers with Statins May Decrease All-Cause Mortality in Patients with Cardiovascular Diseases and Locally Advanced Unresectable Non-Small-Cell Lung Cancer after Chemoradiotherapy.
Cancers (Basel)
; 15(4)2023 Feb 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36831618
13.
Five-Year Survival Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Metastatic Non-Small-Cell Lung Cancer in CheckMate 227.
J Clin Oncol
; 41(6): 1200-1212, 2023 02 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36223558
14.
Systemic and Intracranial Outcomes With First-Line Nivolumab Plus Ipilimumab in Patients With Metastatic NSCLC and Baseline Brain Metastases From CheckMate 227 Part 1.
J Thorac Oncol
; 18(8): 1055-1069, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37146754
15.
Safety of First-Line Nivolumab Plus Ipilimumab in Patients With Metastatic NSCLC: A Pooled Analysis of CheckMate 227, CheckMate 568, and CheckMate 817.
J Thorac Oncol
; 18(1): 79-92, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36049658
16.
[Gefitinib in patients with advanced non-small-cell lung cancer]. / Gefitynib u chorych na niedrobnokomórkowego raka pluca w zaawansowanym stadium.
Pneumonol Alergol Pol
; 80(5): 439-49, 2012.
Artigo
em Polonês
| MEDLINE | ID: mdl-22926905
17.
Crizotinib in the treatment of non-small-cell lung carcinoma.
Contemp Oncol (Pozn)
; 16(6): 480-4, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-23788933
18.
Do We Need TNM for Tracheal Cancers? Analysis of a Large Retrospective Series of Tracheal Tumors.
Cancers (Basel)
; 14(7)2022 Mar 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35406437
19.
RET Proto-Oncogene-Not Such an Obvious Starting Point in Cancer Therapy.
Cancers (Basel)
; 14(21)2022 Oct 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36358717
20.
Real-World Testing Practices, Treatment Patterns and Clinical Outcomes in Patients from Central Eastern Europe with EGFR-Mutated Advanced Non-Small Cell Lung Cancer: A Retrospective Chart Review Study (REFLECT).
Curr Oncol
; 29(8): 5833-5845, 2022 08 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36005198